Study Shows Quantose IR(TM) Measures Insulin Sensitivity Better Than A1C Test for Prediabetes
March 18, 2015 16:24 ET
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., March 18, 2015 (GLOBE NEWSWIRE) -- Metabolon, Inc. announced results from a study using samples from the long-term ACT NOW diabetes prevention study of prediabetic...
Newly Published Results Support Clinical Validity of Quantose IGT(TM) Diabetes Test
January 20, 2015 14:28 ET
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., Jan. 20, 2015 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, announced that results from a study of its Quantose IGT™ test were recently...
Metabolon's Platform for Clinical Triaging of Inborn Errors of Metabolism Verified by Baylor College of Medicine
October 22, 2014 11:46 ET
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C. and HOUSTON, Oct. 22, 2014 (GLOBE NEWSWIRE) -- Metabolon, Inc., a global leader in metabolomics, announced today that its Global Metabolomic-Assisted Pathway Screen (MAPS)...
Metabolon's Quantose(TM) Prediabetes Tests Now Available in Europe Through Collaboration With Metdia Biotech
September 17, 2014 11:05 ET
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 17, 2014 (GLOBE NEWSWIRE) -- Metabolon, Inc., a global leader in metabolomics, announced today that it has partnered with Metdia Biotech, S.L. to commercialize its...
Metabolon and Baylor College of Medicine Partner to Launch Global Metabolomic-Assisted Pathway Screen (MAPS) for Inborn Errors of Metabolism
September 03, 2014 15:10 ET
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C. and HOUSTON, Sept. 3, 2014 (GLOBE NEWSWIRE) -- Metabolon, Inc. and Baylor College of Medicine announced today that they have entered into a two-year, exclusive agreement...
Metabolon to Sponsor Study at Geisinger Medical Center With Quantose IR to Monitor Prediabetes Therapy
June 23, 2014 16:16 ET
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., June 23, 2014 (GLOBE NEWSWIRE) -- Metabolon, Inc., a global leader in metabolomics, announced today that it will sponsor a pilot study to evaluate its Quantose IRTM test...
New Data on Metabolon's Prediabetes Test to be Featured in Two Poster Presentations at ADA Conference
June 12, 2014 12:22 ET
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., June 12, 2014 (GLOBE NEWSWIRE) -- Metabolon, Inc., a global leader in metabolomics, announces that two posters highlighting data from studies using its Quantose IGTTM...
Metabolon Announces Quantose IR Test Launched in Mexico to Help Prevent Type 2 Diabetes
June 04, 2014 15:34 ET
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., June 4, 2014 (GLOBE NEWSWIRE) -- Metabolon, a global leader in metabolomics, announced today that its Quantose IR™ prediabetes test is now available to physicians...